Weiss Multi-Strategy Advisers’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-94,000
Closed -$2.36M 666
2017
Q2
$2.36M Sell
94,000
-21,000
-18% -$520K 0.1% 264
2017
Q1
$3.08M Buy
115,000
+5,000
+5% +$138K 0.12% 207
2016
Q4
$2.88M Sell
110,000
-14,000
-11% -$346K 0.14% 153
2016
Q3
$3.1M Sell
124,000
-14,510
-10% -$338K 0.19% 162
2016
Q2
$3M Sell
138,510
-58,450
-30% -$1.04M 0.23% 136
2016
Q1
$2.95M Sell
196,960
-33,040
-14% -$554K 0.13% 214
2015
Q4
$5.04M Hold
230,000
0.35% 73
2015
Q3
$3.63M Sell
230,000
-42,000
-15% -$673K 0.16% 123
2015
Q2
$3.89M Sell
272,000
-4,500
-2% -$76.2K 0.15% 169
2015
Q1
$4.78M Sell
276,500
-23,500
-8% -$415K 0.21% 127
2014
Q4
$5.38M Sell
300,000
-10,000
-3% -$161K 0.19% 119
2014
Q3
$4.07M Sell
310,000
-25,000
-7% -$337K 0.1% 219
2014
Q2
$4.81M Hold
335,000
0.1% 215
2014
Q1
$4.27M Sell
335,000
-60,000
-15% -$783K 0.09% 244
2013
Q4
$3.95M Hold
395,000
0.09% 263
2013
Q3
$5.2M Buy
395,000
+80,000
+25% +$1.05M 0.11% 213
2013
Q2
$4.5M Buy
+315,000
New +$3.96M 0.13% 222

Other funds holding NXTM

Weiss Multi-Strategy Advisers's NXTM Position: Q3 2017 in Review

Weiss Multi-Strategy Advisers sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 94,000 shares — an estimated $2.36M sold.

Weiss Multi-Strategy Advisers first reported a position in NXTM in Q2 2013 and held it in 17 quarters. The position peaked at $5.38M in Q4 2014. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Weiss Multi-Strategy Advisers reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 94,000 NxStage Medical Inc. shares in Q3 2017, an estimated $2.36M.
  • Weiss Multi-Strategy Advisers first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 17 quarters.
  • Weiss Multi-Strategy Advisers's NxStage Medical Inc. position peaked at $5.38M in Q4 2014.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.